NPM1 and acute myeloid leukemia: PLA2G4A overexpression contributed to the malignant phenotype of AML cells together with its partners and is correlated to a poor prognosis in the patients with non-M3/NPM1 wildtype or Hoxa9- and Meis1-dependent AML (16, 17).